Drug Index

NEOMYCIN SULFATE

Generic: NEOMYCIN SULFATE

Review priority: STANDARD Marketing status: Discontinued

Route: ORAL
Class: General Medications
Safety profile: generic
Latest regulatory update: 27 Mar 2025, 12:00 am (UTC)

Structured Monograph

Approval overview NEOMYCIN SULFATE is listed in Drugs@FDA under application 204435 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient NEOMYCIN SULFATE Form and strength TABLET;ORAL - 500MG Sponsor CHARTWELL MOLECULAR Submission history Latest submission status date: 2025-03-27 00:00:00. Submission type: SUPPL.